10x Genomics (TXG) Total Liabilities (2018 - 2026)

10x Genomics has disclosed Total Liabilities across 9 years of filings, most recently posting $204.5 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 1.05% year-over-year to $204.5 million; the TTM figure through Jun 2026 stood at $204.5 million (down 1.05% YoY), while the FY2025 annual figure was $245.0 million, up 17.52% from the prior year.
• Total Liabilities came in at $204.5 million for Q2 2026 at 10x Genomics, up from $201.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $245.0 million in Q4 2025 to a low of $196.3 million in Q2 2023.
• Average Total Liabilities over 5 years is $212.4 million, with a median of $207.6 million recorded in 2024.
• Year-over-year, Total Liabilities dropped 9.97% in 2023 and climbed 17.52% in 2025.
• Over 5 years, Total Liabilities stood at $223.2 million in 2022, then increased by 0.39% to $224.1 million in 2023, then dropped by 6.96% to $208.5 million in 2024, then grew by 17.52% to $245.0 million in 2025, then slipped by 16.54% to $204.5 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $204.5 million in Q2 2026, $201.4 million in Q1 2026, and $245.0 million in Q4 2025.